Detection of K-ras mutations in lung carcinomas: Relationship to prognosis

Clinical Cancer Research

Volumn 2, Issue 2, 1996, Pages 411-418

  Keohavong, Phouthone ^a   DeMichele, Mary Ann A ^b   Melacrinos, Alea C ^a   Landreneau, Rodney J ^c   Weyant, Robert J ^c   Siegfried, Jill M ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; ONCOGENE K RAS; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; SURVIVAL RATE;

EID: 9044221762     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barbacid, M. ras genes. Annu. Rev. Biochem., 56: 779-827, 1987.
2. Trahy, M , and McCormick, F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science (Washington DC), 238: 542-545, 1987.
3. Adari, H., Lowy, D. R., Willumsen, B. M., Der, C. J , and McCormick, F. Guanosine triphosphate activating protein (GAP) interacts with the p21 ras effector binding. Science (Washington DC), 240: 518-521, 1988.
4. Cales, C., Hancock, J. F., Marshall, C. J., and Hall A. The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product. Nature (Lond.), 332: 548-551, 1988.
5. Vogel, U S., Dixon, R. A. F., Schaber, M. D., Diehl, R. E., Marshall, M. S., Scolnick, E. M., Sigal, I. S., and Gibbs, J. B. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature (Lond.), 335: 90-93, 1988.
6. McCormick, F. ras GTPase activating protein: signal transmitter and signal terminator. Cell, 56: 5-8, 1989.
7. Bos, J. L. The ras gene family and human carcinogenesis. Mutat. Res., 195: 255-271, 1988.
8. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1989.
9. Rodenhuis, S., Slebos, R. J., Boot, A. J. M., Evers, S. G., Mooi, W. J., Wagenaar, S. S., van Bodegom, P. C., and Bos, I. L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res., 48: 5738-5741, 1988.
10. Bos, J. L., Fearon, E. R., Hamilton, S. R., Verlaan-de Vries, M., Van Boom, J. H., Van der Eb, E. J., and Vogelstein, B. Prevalence of ras gene mutations in human colorectal cancer. Nature (Lond.), 327: 298-303, 1987.
11. Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., and Perucho, M. Detection of high incidence of K-ras oncogene during human colon tumorigenesis. Nature (Lond.), 327: 298-303, 1987.
12. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most of human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
13. Smit, V. T., Boot, A. J. M., Smits, A. M. M., Fleuren, G. J., Cornelisse, C. J., and Bos, J. L. K-ras codon 12 mutations occur very frequently in pancreas adenocarcinomas. Nucleic Acids Res., 16: 7773-7782, 1988.
14. Van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Lomans, J., Verbruggen, M., Van de Bersselar, R., Devilee, P., Cornelisse, C., Bos, J. L., Yarnold, J., and Nusse, R. Oncogene activation in human breast cancer Cancer Cells (Cold Spring Harbor), 7: 385-391, 1989.
15. Visvanathan, K. V., Pocock, R. D., and Summerhayes, I. C. Preferential and novel activation of H-ras in human bladder carcinomas. Oncogene Res., 3: 77-86, 1988.
16. Suzuki, Y., Orita, M., Shiraishi, M., Hayashi, K., and Sekiya, T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene, 5: 1037-1043, 1990.
17. Mitsudomi, T., Viallet, J., Mulshine, J. L., Linnoila, R. I., Minna, J. D., and Gazda, A. F. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6: 1353-1362, 1991.
18. Sugio, K., Ishida, T., Yokoyama, H., Inoue, T., Sugimachi, K., and Sasazuki, T. ras gene mutation as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res., 52: 2903-2906, 1992.
19. Rodenhuis, S., and Slebos, R. J. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52 (Suppl.): 2665s-2669s, 1992.
20. Mullis, K. B., and Faloona, F. A. Specific synthesis of DNA synthesis in vitro via a catalyzed polymerase chain reaction. Methods Enzymol., 155: 335-350, 1987.
21. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. G., Higuchi, R., Horn, G. T., Mullis, K. B., and Erlich, H. A. Primer-directed enzymatic amplification of DNA with a thermo-stable DNA polymerase. Science (Washington DC), 239: 487-491, 1988.
22. Fischer, S. H., and Lerman, L. S. DNA fragments differing by single base-pair substitutions separated in denaturing gradient gels: correspondence with melting theory. Proc. Natl. Acad Sci. USA, 80: 1579-1583, 1983.
23. Keohavong, P., and Thilly, W. G. Mutational spectrometry: a general approach for hotspot point mutations in selectable genes. Proc. Natl. Acad. Sci. USA, 89: 4623-4627, 1992.
24. Sheffield, V. C., Cox, D. R., Lerman, L. S., and Myers, R. M. Attachment of a 40-base-pair G+C rich sequence to genomic DNA fragments by polymerase chain reaction results in improved detection of single base changes. Proc. Natl. Acad. Sci. USA, 86: 232-236, 1991.
25. Cariello, N F., Keohavong, P., Kat, A. G., and Thilly, W. G. Molecular analysis of complex human cell population: mutational spectra of MNNG and ICR-191 Mutat. Res, 231: 165-176, 1990.
26. Keohavong, P., and Thilly, W. G. Fidelity of DNA polymerases in DNA amplification. Proc. Natl Acad. Sci. USA, 86: 9253-9257, 1989.
27. Seeburgh, P. H. Colby, W. W., Capon, D. J., Goeddel, D. V., and Levinson, A. D Biological properties of human c-H-ras genes mutated at codon 12. Nature (Lond.), 312: 71-75. 1984.
28. Husgafvel-Prusiainen, K., Hackman, P., Ridanpaa, M., Anttila, S., Karjalainen, A., Partanen, T., Taikina-Aho, O., Heikkila, L , and Vaino, H. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int. J. Cancer, 53: 250-256, 1993.
29. Kobayashi, T., Tsuda, H., Noguchi, M., Hirohashi, S., Shimosato, Y., Goya, T., and Hayata, Y. Association of point mutation in c-K-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer (Phila.), 66: 289-294, 1990.
30. Slebos, R. J. C., Hruban, R. H., Dalesio, O., Mooi, W. J., Offenhaus, G. J. A., and Rodenhuis, S. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J. Natl. Cancer Inst., 83: 1024-1027, 1991
31. Mazur, M., and Glickman, B. W. Sequence specificity of mutations induced by benzo(a)pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells. Somatic Cell Mol. Genet., 14: 393-400, 1988.
32. Chen, R. H., Mahe, R. H , and McCormick, J. J. Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo(a)pyrene in the coding region of the HPRT gene. Proc. Natl. Acad. Sci USA, 87: 8680-8684, 1990.
33. Belinsky, S. A., Devereux, T. R., Maronpot, R. R., Stoner, G. D., and Anderson, M. W. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogenes and lung tumors from A/J mice treated with nitrosamines. Cancer Res., 49: 5305-5311, 1989.
34. Prosperi, M. T., Even, J., Calvo, F., Lebeau, J., and Goulin, G. Two adjacent mutations at position 12 activate the K-ras 2 oncogene of a human mammary cell line. Oncogene Res., 1: 121-128, 1987.
35. Mitsudomi, T., Steinberg, S. M., Oie, H. K., Mulshine, J. L., Phelps, R., Viallet, J , Pass, H , Minna, J. D., and Gazda, A. F. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res., 51: 4999-5002, 1991.
36. H genes mutated at codon 61, Cell, 44: 167-176, 1986.